Responses
Abstract
Free Communications
EFFICACY, PATTERNS OF RELAPSE AND SAFETY OF ADJUVANT TREATMENT WITH INTRAPERITONEAL (I.P.) YTTRIUM-90-LABELLED HMFG1 MONOCLONAL ANTIBODY (R1549) IN EPITHELIAL OVARIAN CANCER (EOC)
Compose a Response to This Article
Other responses
No responses have been published for this article.